Blood pressure and blood glucose telemonitoring in seniors

Not Applicable

• Conditions: Prevention of cardiovascular disease in patients with diabetes and arterial hypertension; Circulatory System

• Registration Number: ISRCTN31471852
• Lead Sponsor: Community Health Centre Ljubljana

Brief Summary

2022 Protocol article in https://doi.org/10.2478/sjph-2022-0029 (added 07/03/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-10-05
• Last Update Posted: 26 June 2023
• Study Completion: 2023-09-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

1. =65 years of age
2. AH and T2DM
3. Diagnosis of AH and T2DM for at least 1 year
4. Capability of smartphone use

Exclusion Criteria

1. <65 years of age
2. T2DM on insulin treatment
3. Type 1 diabetes or gestational diabetes
4. Cognitive impairment

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Systolic blood pressure measured with standardised BP monitors at baseline, 6 months, and 12 months<br>2. Glycated haemoglobin assessed with laboratory testing at baseline and 12 months.

Secondary Outcome Measures

Name	Time	Method
1. Diastolic blood pressure measured with standardised BP monitors at baseline, 6 months, and 12 months <br>2. Lipid profile assessed with laboratory testing at baseline and 12 months <br>3. Glomerular filtration rate assessed with laboratory testing at baseline and 12 months <br>4. Body mass index assessed with standardised scales at baseline and 12 months <br>5. Appraisal of diabetes measured with the Appraisal of Diabetes scale at baseline and 12 months <br>6. Depressive symptoms measured with the Patient Health Questionnaire-9 at baseline and 12 months <br>7. Anxiety symptoms measured with the General Anxiety Disorder-7 questionnaire at baseline and 12 months